Award Lecture Highlights Tumor Evolution Through Liquid Biopsy

IASLC’s Global Reach a Strength on the Road to a Cure for Lung Cancer

Tumor Growth Rate as a Guide for Precision Lung Cancer Therapy

Patient Perspective: The Promise of Personalized Medicine

Cancer Misinformation: Its Impact on Patients and Mitigation Strategies

A Look at Veliparib Plus Chemotherapy for First-Line Treatment of Advanced NSCLC

Study Provides Insights That May Inform Prevention, Management of Mesothelioma

TIL Therapy Endures for Carefully Selected Patients: A Q&A with Dr. Benjamin C. Creelan

Optimal Pathologic Staging of Lung Cancer Depends on More Than the Pathologist

Quality of Life After VATS and SABR for Early-stage Lung Cancer: The Lilac Study

Early Palliative Care: A European Perspective

Valuable Intersections: Maximizing Career Opportunities Arising From The Relationship Between Academia and Industry